Recent events, such as the service fee cuts in Alberta, underscore the volatility of government funding and highlight the need for pharmacies to diversify their revenue streams.
Deals like the recent preferred provider agreement to supply specialty drugs are not only anti-competitive for business, they also restrict patients’ choice of where to obtain healthcare and ultimately, reduce the incentives for pharmacies to innovate.